A patient in a phase 2 trial has received the first dose of a novel cancer vaccine plus Keytruda for solid skin cancer tumors. A patient in a phase 2 trial has received the first dose of a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results